Search

Your search keyword '"J. Oddens"' showing total 42 results

Search Constraints

Start Over You searched for: Author "J. Oddens" Remove constraint Author: "J. Oddens"
42 results on '"J. Oddens"'

Search Results

2. Ontwikkelingen in het verlichtingsonderzoek sinds het jaar 2000. Ter inleiding

4. C-reactive protein, an indicator for maintained response or remission to infliximab in patients with Crohn's disease: a post-hoc analysis from ACCENT I

5. Comprehensive counseling about combined hormonal contraceptives changes the choice of contraceptive methods: results of the CHOICE program in Sweden

6. The Political Culture of the Sister Republics, 1794-1806: France, the Netherlands, Switzerland, and Italy

8. Influence of structured counseling on women's selection of hormonal contraception in Israel: results of the CHOICE study

10. Women’s satisfaction with birth control: a population survey of physical and psychological effects of oral contraceptives, intrauterine devices, condoms, natural family planning, and sterilization among 1466 women

12. Factors influencing women's selection of combined hormonal contraceptive methods after counselling in 11 countries: results from a subanalysis of the CHOICE study

13. Women’s perceptions and reasons for choosing the pill, patch, or ring in the CHOICE study: a cross-sectional survey of contraceptive method selection after counseling

14. The Primacy of Parliamentary Proceedings: The Members of the First Dutch National Assembly and the Dagverhaal

15. The CHOICE study: effect of counselling on the selection of combined hormonal contraceptive methods in 11 countries

16. No extended sphere: the Batavian understanding of the American Constitution and the problem of faction

17. Comprehensive counseling about combined hormonal contraceptives changes the choice of contraceptive methods: results of the CHOICE program in Sweden

18. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis

20. Factors influencing women's satisfaction with birth control methods

21. Influence of structured counseling on women's selection of hormonal contraception in Israel: results of the CHOICE study

22. Mucosal Healing in Patients with Ulcerative Colitis Associates with a Reduced Colectomy Risk, High Incidence of Symptomatic Remission, and Corticosteroid-Free State

23. Determinants of long-term hormone replacement therapy and reasons for early discontinuation

24. Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, and hormone replacement therapy use

25. A scenario study of oral contraceptive use in Japan. Toward fewer unintended pregnancies

26. Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance

27. Consistency of gonadotrophin products

28. 708 Side effects of BCG in the treatment of intermediate and high risk Ta T1 papillary carcinoma of the bladder: Results from EORTC GU Cancers Group randomized study 30962 comparing 1/3 dose vs full dose during 1 or 3 years

29. Contraceptive practice and attitudes in Sweden 1994

30. Female voice changes around and after the menopause--an initial investigation

31. Informing patients about clinical trials

32. Determinants of contraceptive use: from birth control to fertility awareness

33. Consistency of gonadotrophin products – further comment

34. Committees should devise special forms for the social sciences

35. Men in black: The silhouette portraits of the members of the first Dutch National Assembly

36. Transperineal laser ablation as treatment for benign prostatic obstruction: Safety, feasibility and functional outcomes-A pilot study.

37. The Greatest Right of Them All: The Debate on the Right to Petition in the Netherlands from the Dutch Republic to the Kingdom (c. 1750-1830).

38. Reply to Stephen B. Williams and Ashish M. Kamat's Letter to the Editor re: Samantha Cambier, Richard J. Sylvester, Laurence Collette, et al. EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin. Eur Urol 2016;69:60-9.

39. EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin.

40. Side effects of Bacillus Calmette-Guérin (BCG) in the treatment of intermediate- and high-risk Ta, T1 papillary carcinoma of the bladder: results of the EORTC genito-urinary cancers group randomised phase 3 study comparing one-third dose with full dose and 1 year with 3 years of maintenance BCG.

41. Final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guérin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenance.

42. Duration of androgen suppression in the treatment of prostate cancer.

Catalog

Books, media, physical & digital resources